Cargando…
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
According to a recent World Health Organization estimate, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has spread globally, infecting nearly 100 million people worldwide by January 2021. Patients with chronic liver diseases (CLD), part...
Autores principales: | Cornberg, Markus, Buti, Maria, Eberhardt, Christiane S., Grossi, Paolo Antonio, Shouval, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867401/ https://www.ncbi.nlm.nih.gov/pubmed/33563499 http://dx.doi.org/10.1016/j.jhep.2021.01.032 |
Ejemplares similares
-
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
por: Marjot, Thomas, et al.
Publicado: (2022) -
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
por: Boettler, Tobias, et al.
Publicado: (2020) -
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients
por: Cornberg, Markus, et al.
Publicado: (2021) -
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
por: Boettler, Tobias, et al.
Publicado: (2020) -
Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study
por: Agbim, Uchenna, et al.
Publicado: (2020)